UCB (PK) Stock Quote UCBJY - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

90.98

Bid

89.05

Ask

91.79

Volume

6,414

90.04 Day's Range 90.99

34.85 52 Week Range 91.89

Market Cap

34.499B

Previous Close

89.42

Open

90.04

Last Trade

200

90.98

(formt)

Last Trade Time

Financial Volume

$ 581,758

VWAP

90.7013

Average Volume (3m)

13,590

Shares Outstanding

379,189,796

Dividend Yield

1.01%

PE Ratio

183.51

Earnings Per Share (EPS)

0.9

Revenue

4.87B

Net Profit

343M

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

Pharmaceutical Preparations

Industry

Chemicals & Allied Products

Website

www.ucb.com

Headquarters

Brussels, Brussels-capital Region, Bel

Founded

1928

UCB (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker UCBJY. The last closing price for UCB (PK) was $89.42. Over the last year, UCB (PK) shares have traded in a share price range of $ 34.85 to $ 91.89.

UCB (PK) currently has 379,189,796 shares outstanding. The market capitalization of UCB (PK) is $33.91 billion. UCB (PK) has a price to earnings ratio (PE ratio) of 183.51.

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services Judges highlight value-added partnership and finance transformation as leading examples of innovation in...

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S.

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to...

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015 PR Newswire ATLANTA, May 16, 2015 ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company...

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam - Major milestone for brivaracetam is latest step towards UCB goal of extending treatment...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annua...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annual Meeting PR Newswire ATLANTA, Dec. 8, 2014 ATLANTA, Dec. 8, 2014...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy -- Primary efficacy and safety...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.655	0.725159147523	90.325	91.89	87.916	6042	89.42824937	DR
4	1.065	1.18445198243	89.915	91.89	87.916	4607	89.84467274	DR
12	17.14	23.2123510293	73.84	91.89	73.84	13590	82.25661941	DR
26	32.43	55.3885567891	58.55	91.89	58.282	19235	72.33401947	DR
52	45.83	101.506090808	45.15	91.89	34.85	17039	59.54361957	DR
156	36.46	66.8745414527	54.52	91.89	32.82	20902	48.07495743	DR
260	55.88	159.202279202	35.1	91.89	32.45	19657	50.08854686	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GENNGenesis Healthcare Inc (CE)	$ 0.0011 (109,900.00%)	2.64k
PHCFFPuhui Wealth Investment Management Company Ltd (CE)	$ 0.0001 (9,900.00%)	100
KLDOKaleido Biosciences Inc (CE)	$ 0.0001 (9,900.00%)	154
EGRNFChina Evergrande Group (CE)	$ 0.0001 (9,900.00%)	3.86k
GWHPGlobal Wholehealth Partners Corporation (CE)	$ 0.0001 (9,900.00%)	19.55k
THCBFTHC Biomed International Limited (CE)	$ 0.000001 (-100.00%)	100
ANTGFAdvantagewon Oil Corporation (CE)	$ 0.000001 (-99.99%)	2.46k
GKINGuskin Gold Corporation (CE)	$ 0.000001 (-99.97%)	1.5k
MOBOMobile Lads Corporation (CE)	$ 0.000001 (-99.97%)	40k
JUVAFJuva Life Inc (CE)	$ 0.000001 (-99.95%)	4.35k
IJJPIJJ Corporation (PK)	$ 0.0006 (100.00%)	305.25M
EPAZEpazz Inc (PK)	$ 0.0007 (40.00%)	257.54M
HCMCHealthier Choices Management Corporation (PK)	$ 0.0001 (0.00%)	219.94M
HMBLHUMBL Inc (PK)	$ 0.0002 (100.00%)	94.6M
RONNRonn Motor Group Inc (PK)	$ 0.0008 (-20.00%)	88.56M